Authors: Maurel, J Zorrilla, M Puertolas, T Anton, A Herrero, A Artal, A Alonso, V Martinez-Trufero, J Puertas, MD

Citation: J. Maurel et al., Phase I trial of weekly gemcitabine at 3-h infusion in refractory, heavilypretreated advanced solid tumors, ANTI-CANC D, 12(9), 2001, pp. 713-717

Authors: Isla, D Rosell, R Sanchez, JJ Carrato, A Felip, E Camps, C Artal, A Gonzalez-Larriba, JL Azagra, P Alberola, J Martin, C Massuti, B

Citation: D. Isla et al., Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer, J CL ONCOL, 19(4), 2001, pp. 1071-1077

Authors: Maurel, J Martinez-Trufero, J Artal, A Martin, C Puertolas, T Zorrrilla, M Herrero, A Anton, A Rosell, R

Citation: J. Maurel et al., Prognostic impact of bulky mediastinal lymph nodes (N2 > 2.5 cm) in patients with locally advanced non-small-cell lung cancer (LA-NSCLC) treated withplatinum-based induction chemotherapy, LUNG CANC, 30(2), 2000, pp. 107-116

Authors: Cardenal, F Lopez-Cabrerizo, MP Anton, A Alberola, V Massuti, B Carrato, A Barneto, I Lomas, M Garcia, M Lianes, P Montalar, J Vadell, C Gonzalez-Larriba, JL Nguyen, B Artal, A Rosell, R

Citation: F. Cardenal et al., Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lungcancer, J CL ONCOL, 17(1), 1999, pp. 12-18

Authors: Anton, A Diaz-Fernandez, N Larriba, JG Vadell, C Masutti, B Montalar, J Barneto, I Artal, A Rosell, R

Citation: A. Anton et al., Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC), LUNG CANC, 22(2), 1998, pp. 139-148